Enzalutamide Improves Survival for Men with Metastatic Hormone-Sensitive Prostate Cancer (IMAGE)

Dana-Farber Cancer Institute

Enzalutamide Improves Survival for Men with Metastatic Hormone-Sensitive Prostate Cancer

Caption

Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.